Patients affected by lymphoid malignancies (LM) are frequently immune‐compromised,
suffering increased mortality from COVID‐19. This prospective study evaluated serological …

Individuals with hematological malignancies and hematopoietic stem cell transplant (HCT)
recipients are immunologically heterogenous groups with varying degrees of …

Patients with cancer are at particular risk for infection but also have diminished vaccine
responses, usually quantified by the level of specific antibodies. Nonetheless, vaccines are …

Data on the effect of booster SARS‐CoV‐2 vaccination are mainly focused on humoral
immunogenicity, while the kinetics of vaccine‐induced cellular response and its correlation …

Simple Summary Patients who recently received a stem cell transplantation are at greater
risk for infection due to impairment of their immune system. In order to prevent severe …

Murabutide (MB) is a synthetic immunomodulator recognized by the nucleotide-binding
oligomerization domain-containing protein 2 (NOD2) receptor on mammalian cells. MB has …

The seasonal influenza A vaccine is recommended for patients with myeloproliferative
neoplasms (MPNs). We hypothesised that immune deregulation associated with MPNs may …

This is a randomized trial evaluating the safety and immunogenicity of one or two doses of
2009 pandemic H1N1 influenza vaccination in adults with lymphoid malignancies. Adults …

The article presents the findings of the assessment of national and state vaccination
coverage among adolescents in the US aged 13 to 17 years from 2010-2011 using data …

SARS-CoV-2 vaccines offered great hope in controlling the worldwide COVID-19 pandemic.
At present, SARS-CoV-2 vaccines have shown excellent efficacy to prevent COVID-19 but …